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Marek’s disease (MD) is a lymphoproliferative disease induced by Marek’s disease virus
(MDV) infection. To augment vaccination measures in MD control, host genetic resistant
to MD becomes obviously more and more important.To elucidate the mechanism of MD-
resistance, most of researches were focused on the genetic differences between resistant
and susceptible chickens. However, epigenetic features between MD resistant and sus-
ceptible chickens are poorly characterized. Using bisulﬁte pyrosequencing method, we
foundsomecandidategeneshavehigherpromotermethylationintheMD-susceptible(L72)
chickens than in the MD-resistant (L63) chickens.The hypermethylated genes, involved in
cellular component organization, responding to stimulus, cell adhesion, and immune sys-
tem process, may play important role in susceptibility to disease by deregulation of these
genes. MDV infection induced the expression changes of all three methyltransferases
genes (DNMT1, DNMT3a, and DNMT3b) in both lines of chickens. The DNMT1 was up-
regulated in L72, whereas the DNMT3b was down-regulated in L63 at 21dpi. Interestingly,
a dynamic change of promoter methylation was observed during MDV life cycle. Some
genes, including HDAC9, GH, STAT1, CIITA, FABP3, LATS2, and H2Ac, showed differen-
tial methylation behaviors between the two lines of chickens. In summary, the ﬁndings
from this study suggested that DNA methylation heterogeneity and MDV infection induced
methylation alterations differences existed between the two lines of chickens.Therefore,
it is suggested that epigenetic mechanisms may be involved in modulating the resistance
and/or susceptibility to MD in chickens.
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INTRODUCTION
Marek’s disease (MD) is a lymphoproliferative disease of chick-
ens caused by Marek’s disease virus (MDV) with pathological
features including mononuclear cell-inﬁltration in the periph-
eral nerves, skin, and muscle (Davison and Nair, 2004). MDV
is classiﬁed into the Mardivirus genus due to its genome content
(Davison, 2002) and biological effect on lymphocytes like EBV
(Epstein,2001). MDV life cycle in its host can be divided into four
phases, including an early cytolytic phase from 2 to 7days post
infection (dpi), a latency phase around 7–10dpi, a late cytolytic
phase starting from 18dpi and a proliferation phase after 28dpi
(Calnek, 1986, 2001). Although MD is controlled by vaccination,
the virulence of MDV has being evolved over time and resulted in
more severe brain edema and acute deaths even after vaccination
(Witter, 1997; Osterrieder et al., 2006). MD remains a problem
in the poultry industry worldwide (Churchill et al., 1969). Since
theinheritanceandresistancetoMDwasﬁrstobserved(Asmund-
son and Biely,1932),MD-resistant and -susceptible chickens have
been bred by those including Stone (lines 6 and 7; Bacon et al.,
2000), Hutt, and Cole (lines N and P; Davison and Nair, 2004).
Nowadays, the selection of genetically disease resistant chickens
is especially important in MD control. A better understanding in
themechanismsof MD-resistanceand-susceptibilityshouldbeof
great value in developing better strategies to further prevent and
control MD.
In recent years,most of the studies are focused on genetic vari-
ations between MD-resistant and susceptible chickens (Gilmour
et al., 1976; Fredericksen et al., 1977; Kaiser et al., 2003; Sarson
et al., 2008a). However, little is done on epigenetic differences
between the two kinds of chickens. Epigenetics is the study of
alterations in phenotypes that are not brought about by changes
in DNA sequences, but by factors including DNA methylation,
histone modiﬁcations, and so on (Allis et al., 2006). DNA methy-
lation is known as a post-replication modiﬁcation found on the
5-C position of cytosine mainly in CpG dinucleotides, generated
andmaintainedbythreemethyltransferases–DNMT1,DNMT3a,
and DNMT3b (Allis et al., 2006). In mammals, DNA methylation
was found playing important role in development, imprinting,
carcinogenesis, and other diseases (Feinberg and Tycko, 2004;
Feng et al., 2010). Notably, we found two DNA mutations in
DNMT3b (Yu et al., 2008a) and a higher promoter methylation
level of ALVE and TVB in the spleen of MD-susceptible chickens
(L72) compared to that of MD-resistant chickens (L63; Yu et al.,
2008b), and the methylation level in CD4 promoter region was
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down-regulated in the former but not in the later at 21dpi (Luo
et al.,2011).
To advance the understanding of functional patterns of DNA
methylationindiseaseresistanceorsusceptibility,weextendedthe
scopeof examinationto18interestedgenes,whichincludeSTAT1,
CIITA, NK-lysin, CD44, IL12, and GH1 that the expression levels
of these gene are alterable upon MDV challenge (Liu et al., 2001;
Abdul-Careemetal.,2006;ParcellsandBurgess,2008;Sarsonetal.,
2008a,b; Heidari et al., 2010; Thanthrige-Don et al., 2010). Some
of the 18 genes were also chosen based on our previous temporal
microarray data, which include FABP3, HDAC9, IL28RA, MON2,
and THBS2 (Luo et al., 2011;Yu et al.,2011).
MATERIALS AND METHODS
ANIMALS, CHALLENGE TRIAL, AND SAMPLE COLLECTION
Speciﬁc pathogen free chickens from two highly inbred White
Leghorn lines, the L63 and L72, were used. Chickens from each of
the lines were divided into two groups. One group was challenged
with a very virulent plus MDV (vv+MDV), 648A passage 40,
intra-abdominallyatday5posthatchata500plaque-formingunit
(PFU) dosage, the other was not challenged and was assigned as
thecontrolgroup.Freshspleensampleswererespectivelycollected
at 5, 10, and 21dpi from both groups, and placed in RNAlater
(Qiagen, Valencia, CA, USA) immediately, and then stored at
−80˚C.
All of the experimental chickens were challenged and main-
tained in a BSL-2 facility at the Avian Disease and Oncology
Laboratory (ADOL), East Lansing, Michigan. The chickens were
handled closely following animal usage procedures established by
the ADOL ACUC committee.
DNA EXTRACTION, BISULFITE TREATMENT, AND PYROSEQUENCING
DNA was extracted from 20∼30mg spleen by NucleoSpin®
Tissue Kits (Macherey-Nagel, Bethlehem, PA, USA). Bisulﬁte
treatment of 1μg DNA per chicken was performed using EZ
DNAMethylation-GoldKit™(ZYMOResearch,Irvine,CA,USA).
Primers for PCR and pyrosequencing were designed with PSQ
Assay Design software (Biotage, Charlotte, NC, USA; Table A1
in Appendix). For cost saving purposes, a universal primer (5 -
GGGACACCGCTGATCGTTTA-3 ) was used in the PCR assays
(Yu et al., 2008a). PCR was carried out using Hotstar Taq DNA
polymerase (Qiagen, Valencia, CA, USA) in 20μl reactions in
iCycler (Bio-Rad, Hercules, CA, USA) Detection System as fol-
lows: samples were denatured at 95˚C for 15min, followed by 50
cycles at 95˚C for 30s, 55–60˚C for 30s, 72˚C for 30s, and then
extended at 72˚C for 10min. DNA methylation level analysis was
performed on the Pyro Q-CpG system (PyroMark ID, Biotage,
Charlotte, NC, USA) as previously described (Colella et al., 2003;
Yu et al.,2008a).
RNA EXTRACTION AND QUANTITATIVE REAL-TIME RT-PCR
RN Afrom30∼50mgspleenwasextractedusingtheRNeasyMini
Kit (Qiagen, USA). Reverse transcription was carried out in 20μl
with 1μg of total RNA by using SuperScriptTM III Reverse Tran-
scriptase (Invitrogen, Carlsbad, CA, USA) and oligo (dT)12–18
primers (Invitrogen, Carlsbad, CA, USA). Primers (Table A2 in
Appendix)forquantitativereal-timeRT-PCRweredesignedusing
Primer3 online primer designer system1. Quantitative real-time
RT-PCR was performed on the iCycler iQ PCR system (Bio-Rad,
USA) in a ﬁnal volume of 20μl using QuantiTect SYBR Green
PCR Kit (Qiagen) with following procedures: denatured at 95˚C
for 15min,followed by 40 cycles at 95˚C for 30s,55–60˚C for 30s,
72˚C for 30s, then extended at 72˚C for 10min. Each reaction
was replicated. The housekeeping gene GAPDH (glyceraldehyde-
3-phosphate dehydrogenase) was used to normalize the loading
amount of cDNA.
FUNCTIONAL ANALYSIS AND STATISTICS
The GO Biological Process analysis of the genes was analyzed by
PANTHER2. Student’s t-test was used to analyze the differences
of the promoter methylation level and the gene expression before
and after MDV infection.
RESULTS
DIFFERENTIAL METHYLATION PATTERNS BETWEEN THE L63 AND L72
Todeterminethedifferentmethylationlevelsof genesbetweenthe
MD-resistant L63 and the MD-susceptible L72 chickens, we ana-
lyzed the DNA methylation status of promoters for 18 genes by
bisulﬁte pyrosequencing method. The results showed that most
of the 18 genes, including LATS2, MON2, IL28RA, STAT1, CD44,
H2Ac, TNFSF10, IL12, FABP3, and CIITA, were hypomethylated
(methylation level <40%); few of them, ITGB5, THBS2, and
HDAC9, had intermediate methylation level (between 40% and
60%),and the rest (IGF2,GH1,NK-lysin,and TGFβ3)h a dh yp e r -
methylation methylation level (>60%) in the control groups of
both lines (Table A3 inAppendix). However,some of the CpGs of
CD82 hadaverylowmethylationlevel(<10%)andothershadan
intermediate methylation level (Table A3 in Appendix).
Differential promoter methylation levels were observed for
ITGB5, THBS2, HDAC9, IL12, CD44, H2AC, and TNFSF10
between the L63 and L72,As showed in Figure 1, the methylation
levels in all the tested CpG sites of the ITGB5, THBS2, HDAC9,
IL12,H2AC weresigniﬁcantlyhigherinL72 thaninL63 (P <0.05;
Figures 1A–E). However, some of the CpG sites in CD44 (CpG
2 and 4) and TNFSF10 (CpG 5) had higher level of methylation
(P <0.05), while some others (CD44 CpG 3; TNFSF10 CpG 1
and 3) had lower methylation levels in L63 than L72 (P <0.05;
Figures 1F,G).
To test if the differential promoter methylation levels of these
genes are related with gene expression, we randomly chose two
genes, ITGB5 and H2Ac, and did quantitative RT-PCR. We found
that the expression levels of the two genes, whose promoter
methylation is higher in L72 chicken, is lower in these chickens
(Figure 2).
Functional analysis of the genes (Figure 3) showed that,
in comparison to the whole gene set we examined in this
experiment, genes with lower methylation levels in L63 are
mainly enriched in cellular component organization, response
to stimulus, cell adhesion, and immune system process. In con-
trast, an under-enrichment of these genes was shown in cell
communication, transport, system process, reproduction, and
1http://frodo.wi.mit.edu/
2http://www.pantherdb.org/
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FIGURE 1 | Differentiated promoter methylation levels between the L63 and L72 chickens observed in ITGβ5 (A),THBS2 (B), HDAC9 (C), IL12 (D), H2Ac
(E), CD44 (F), andTNFSF10 (G).The promoter methylation levels of the genes in spleen were examined by pyrosequencing.The absolute methylation
level for each CpG site from pyrosequencing result was plotted. Solid line: L63; dashed line: L72.* P <0.05, **P <0.01. N =12 for each group. Error bar=SEM.
developmental process. For genes with a varied methylation levels
between L63 and L72, they are over-represented in functions of
cell adhesion and immune system process. However,for the genes
with similar methylation between the L63 and L72, no under or
over-represented biological functions was identiﬁed.
DIFFERENTIAL DNMT1, DNMT3a, AND DNMT3b EXPRESSION INDUCED
BY MDV CHALLENGE
To explore how MDV challenge induces DNA methylation alter-
ation,weﬁrstcheckedif theexpressionsof themethylationagents,
three methyltransferases (DNMT1, DNMT3a, and DNMT3b),
were inﬂuenced over three time points (5, 10, and 21dpi), which
represent the early cytolytic, latent, and later cytolytic phase
of the virus life cycle in the host cells, respectively. Interest-
ingly, similar trends of expression changes were observed at 5
and 10dpi for all three DNMTs in the MDV challenged chick-
ens of both lines (Figure 4), while at 21dpi, the changes were
much more complicated. At 21dpi, the DNMT1 was signiﬁ-
cantly up-regulated in the infected L72 chickens compared to
the L72 control group (P <0.05). The DNMT1 was remained
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unchanged, however, between the infected and uninfected L63
groups (P >0.05; Figure 4A). For DNMT3a, no expression
FIGURE 2 | Expression of ITGB5 (A) and H2Ac (B) in non-infected
chicken samples. N =4 for each group. Error bar=STD.
difference was observed at 21dpi between the infected and non-
infected groups of both lines (P >0.05; Figure 4B). However, the
DNMT3b was signiﬁcantly down-regulated in the infected group
of L63 at 21dpi (P <0.05), but no differential expression was
observedinL72(Figure4C).Overall,theexpressionlevelsofallthe
three DNMTs were signiﬁcantly inducible by MDV infection, but
withvariedalterationtrendsandextentswerefoundoverdifferent
time points and between the infected and non-infected groups as
well as between the chicken lines.
ABERRANT METHYLATION LEVEL INDUCED BY MDV INFECTION
To further study DNA methylation dynamic response to MDV
infection, we tested the promoter methylation of the 18 genes on
5, 10, and 21dpi. Pairwise comparison was performed between
the infected and non-infected age-matched sample groups of
each chicken line for each of the CpG sites. Signiﬁcant methy-
lation level changes (P <0.05) were detected at one or more
CpG sites in all of the genes except THBS2 gene after MDV
challenge. The methylation level changes of the examined genes
were under 30%. The MDV-induced DNA methylation changes
for CIITA, NK-lysin, FABP3, and ITGB5 were 10% above their
unchallenged counterpart for each of the CpG sites. More than
10% methylation change was found in HDAC9 at 5dpi and 7–
10% changes at 21dpi in L72. Most of the genes (12/17) had
signiﬁcant methylation change (P <0.05) at more than one time
point(Table A4 inAppendix;Figure5),exceptforIL12,TNFSF10,
and ITGB5, which were only changed at 5dpi, and CD44, LATS2,
CIITA, which were only changed at 21dpi. In contrast between
the two lines of chickens, more genes in L63 had signiﬁcant
methylation changes at 5dpi, while more genes were observed
with signiﬁcant methylation changes in L72 at 10 and 21dpi
(Figure 6).
DIFFERENTIALLY METHYLATION CHANGES DUE TO MDV CHALLENGE
To compare the contents of the methylation change between L63
and L72, the mean methylation change of all the CpG sites was
FIGURE3|F unctional analysis of the genes by PANTHER.
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FIGURE 4 | Expression of DNA methyltrasferase genes after MDV
infection.The expression of three DNA methyltrasferase genes, DNMT1
(A), DNMT3a (B), and DNMT3b (C), were tested by quantitative real-time
RT-PCR at 5, 10, and 21dpi in chicken spleen both resistant and susceptible
to MD.The relative expression level was normalized to GAPDH gene. Black:
non-infected; white: infected. *P <0.05, **P <0.01. N =4 for each group.
Error bar=SEM.
calculated for each gene. Seven out of the 18 genes (HDAC9, GH,
STAT1, CIITA, FABP3, LATS2, and H2Ac) showed signiﬁcant dif-
ferentially averaged methylation changes (P <0.05) between the
two lines of chickens (Table 1; Figure A1 in Appendix). Func-
tional analysis of the genes with temporal methylation changes
revealed that the genes, related to apoptosis, immune system
process, and response to stimulus, were over-represented at 5dpi
(Figure 6). However, genes, involved in enrichment of cell com-
munication,wereshownat10dpi;Genes,involvedinfunctionality
of cellcycle,cellularcomponentorganization,andtransport,were
over-represented at 10 and 21dpi.
FIGURE 5 |Venn Diagrams of the number of genes have the
methylation change at different time points and in different chicken
lines. (A)The number of genes has the methylation change at 5, 10,
and 21dpi. (B–D)The number of genes has the methylation change
between L63 and L72 at 5, 10, and 21dpi respectively.
FIGURE6|F unctional analysis of the genes have different methylation
change between L63 and L72 at 5, 10, and 21dpi by PANTHER.
DISCUSSION
Thedevelopmentof diseaseresistancehaslongbeenaveryimpor-
tant strategy for control of diseases in farm animals (Bishop et al.,
2010; Luo et al., 2012). A better understanding on the mecha-
nisms of disease resistance will facilitate breeding of more disease
resistant animals, help to better control diseases in farm animal
and also provide better models to learn disease control strategies
for humans. Since the establishment of the non-MHC associ-
ated MD-resistant and -susceptible chicken lines (Line 6 and Line
7), lots of experiments have been done to elucidate the genetic
mechanism of MD-resistance between the two lines of chickens
(Gilmour et al., 1976; Fredericksen et al., 1977; Kaiser et al., 2003;
Sarson et al., 2008a). However, not until recently, our lab started
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Table 1 | Differential DNA methylation change between L63 and L72
after MDV challenge.
Time points (dpi) Gene name DNA methylation
level change
P value
L63 L72
5 GH −4.71 2.95* 0.0146
CIITA 1.95 −7 .51* 0.0298
STAT1 −0.95** 0.42 0.0244
H2Ac 1.11** 2.62** 0.0306
10 FABP3 4.37** −9.21** 0.0002
LATS2 −0.01 0.48** 0.0409
H2Ac 2.53** −0.56 0.0044
21 HDAC9 3.16** 7 .92** 0.0273
GH 0.83 6.07** 0.0096
FABP3 −1.76 4.70** 0.0117
H2Ac 0.78** −1.36 0.0211
*P<0.05, **P<0.01.
to explore their epigenetic differences between the chicken lines,
which provides evidence that DNA methylation may be involved
in MD-resistance or -susceptibility (Yu et al., 2008a,b; Luo et al.,
2011). As we know, although the functions of DNA methyla-
tion in development, imprinting etc. were reported in mammals,
it’s still unclear about its function in disease resistance. Previous
study in human (Jelinek et al., 2011) and plant (Akimoto et al.,
2007) showed that individuals with a higher DNA methylation
level in some particular genes are susceptible to diseases or bac-
terial infection, which is consistent with our ﬁnding that a higher
methylation level of several genes (ITGB5, THBS2, HDAC9, IL12,
and H2Ac) were shown in MD-susceptible (L72) chickens. How-
ever, variable methylation level of CD44 and TNFSF10 between
L63 and L72 indicated that the hypermethylation in susceptible
chickens is not genome-widely. Functioning classiﬁcation showed
thatthehypermethylatedgenesinsusceptiblechickenareshowing
functions of cellular component organization, response to stim-
ulus, cell adhesion, and immune system process. Interestingly,
hypermethylation of genes functioning in regulating cell adhe-
sion was very important for the development of various cancers
in human (Katto and Mahlknecht, 2011). Furthermore, expres-
sion analysis of the hypermethylated genes in the susceptible
chickens showed a lower expression of these genes. The results
indicatedthattherearespeciﬁcpathwaysthatmayinvolveinMD-
susceptibility or -resistance through hyper- or hypo-methylation
of the genes included. In the future, a genome-wide DNA methy-
lation research will be designed, which will help us explore the
mechanisms further.
In previous study, the DNA methyltransferase (DNMTs) were
usually found up-regulated by virus infection in human cells, like
SV40 (Chuang et al., 1997) and EBV (Tsai et al., 2002). How-
ever, dynamic change of DNMTs expression was observed in vivo
during MD life cycle in chicken. The DNMTs were ﬁrst down-
regulated at 5dpi and then up-regulated at 10dpi in both L63
and L72 chickens. Furthermore, different regulations of DNMTs
were observed between the MD-resistant and -susceptible chick-
ens at 21dpi, indicating that late cytolytic phase is a critical time
for DNMTs function in DNA methylation process or tumorigen-
esis. However, the DNMTs expression change was not necessary
for the change of the methylation level change in the genes we
studied. The correlation between DNMTs expression and methy-
lation is upon chickens and time point. There are several reasons
for that: First, other epigenetic mechanisms involve in the methy-
lationchangeduringMDVinfection;second,thechangeddosages
of DNMTs arenotefﬁcientforthechangeof methylationonthese
genes; third, other functions of DNMTs involve. Except for estab-
lishing and maintaining the DNA methylation in cells, DNMTs
also have other functions. The ﬁnding that DNMT1 was only
up-regulated in MD-susceptible chicken is consistent with the
observation that DNMT1 is necessary for establishing and main-
taining the transformation state of cells (Bakin and Curran,1999;
Robert et al., 2003). Similarly, DNMT3B deﬁcient mouse embryo
ﬁbroblasts were found resistant to virus induced transformation
(Soejimaetal.,2003),whichisconsistentwithourﬁndingthatthe
down-regulation of DNMT3b was only shown in MD-resistant
chicken.
Abnormal DNA methylation is a common feature of human
cancer. The fact is that DNA methylation started to be changed
from very early stage of transformation process and a stepwise
or dynamic change was happened during carcinogenesis (Ehrlich,
2009; Novak et al., 2009). Furthermore, DNA methylation mod-
iﬁcations at the promoter regions of genes play a critical role
in the intricate host–virus interaction network (Young et al.,
2000; Zheng et al., 2008). From our results, the dynamic DNA
methylation change during MD progression not only indicated
an interaction between MDV and host gene, but also revealed
the genes with aberrant methylation level may also involve in
virus induced transformation process. During MDV life cycle
in chicken spleen, 5dpi is the early cytolytic phase when B cells
and some T cells were targeted by MDV (Osterrieder et al.,
2006). Virus infection in this stage provokes some apoptosis,
lymphoid lesion, and inﬂammation responses in the immune
organ (Morimura et al.,1996;Baigent and Davison,1999). Differ-
ent methylation change in genes enriched in apoptosis, immune
system process, and response to stimulus suggested that the
expression of these genes maybe differentially regulated between
the MD-resistant and -susceptible chickens, which show differ-
ent response to MDV infection. Although 10 and 21dpi rep-
resent the latency and later cytolytic or transformation stage
of MDV infection, it’s very difﬁcult to differentiate them very
clearly in vivo since the latently infected cells can be mixed with
the transformed cells (Davison and Nair, 2004). So we found
some function enrichments like cell communication and trans-
port are shared at 10 and 21dpi. Genes over-represented in
cell cycle and cell communications have different DNA methy-
lation changes in L63 and L72 chicken. Since genes involve in
cell cycle and cell communication play important role in car-
cinogenesis (Yamasaki et al., 1995; Hanahan and Weinberg, 2000,
2011), these results suggested that DNA methylation may partic-
ipate in MD-resistance by disrupting pathways intriguing tumor
formation.
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In conclusion, we found DNA methylation heterogeneity
between the MD-resistant L63 and -susceptible L72 chickens. The
hypermethylation of genes involved in cellular component orga-
nization,response to stimulus,cell adhesion,and immune system
process may play important role in MD-susceptibility. Different
from other viruses,MDV induces a dynamic expression change in
DNMTs. Differential methylation changes are observed between
resistant and susceptible chickens after MDV infection. All in
all, the differential DNA methylation levels and DNA methyla-
tion level change induced by MDV challenge between the lines of
chickens suggested that DNA methylation may play a role in host
resistance and/or susceptibility to MD.
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APPENDIX
TableA1 | Primers for pyrosequencing analysis of promoter methylation.
Genes Accession No. Primers Sequence
ITGB5 NM_204483 F 5 -GGGACACCGCTGATCGTTTAYGTGYGGAGTTYGTAGAGAT-3 
R5  -CCCTTAAAAACTATCTCRTTCCA-3 
Sequencing 5 -TCTCRTTCCAATTATACAC-3 
Assay 5 -RACRCTACCACCCRCTACRT-3 
CD82 NM_001008470 F 5 -AGCGTTGYGAGTTTTATAGAAGTG-3 
R5  -GGGACACCGCTGATCGTTTA AACCCTCRCTCRACTACTTTACC-3 
Sequencing 5 -AAGTGAGAATAATGTAATGG-3 
Assay 5 -TAGYGGTTAGTAGTTYGGTATTTYGTTGTTATYGTAGYGTTGTAATYGTT-3 
HDAC9 NM_001030981 F 5 -TTGGGATATGGGTTGTCGAAAT-3 
R5  -GGGACACCGCTGATCGTTTA GCTAATACTCTCGTTCGCAACATS 
Sequencing 5 -TGGGTTGTCGAAATAGTT-3 
Assay 5 -TYGYGGGATTGTTGTGYGTGGGYGYGGTAGAAATTATGTTGCGAACGAGA-3 
STAT1 NM001012914 F 5 -TGTAAYGAAGTAAAATAGGYGAGA-3 
R5  -GGGACACCGCTGATCGTTTATCAACCTACACTACRCAACCTAA-3 
Sequencing 5 -TAAAATAGGCGAGATATAAG-3 
Assay 5 -TAYGYGAGTYGTTYGYGAGGTAGGGTCGTT-3 
TGFB5 NM_205454 F 5 -GYGAGGATATTTATTTGGAAGAG-3 
R5  -GGGACACCGCTGATCGTTTA CCCAAAAAATATCACCTCCAAT-3 
Sequencing 5 -GAGTTTGGGTTGGGTA-3 
Assay 5 -TAYGTAGTATTYGGAATTTTGTTYGAAATAGGTTGGTGTTGTTTTTTTTTGYGGAGGATAYGTTAAAGYG-3 
Nk-lysin NM001044680 F 5 -GYGTTAGTTGAATTTTAGAGTTTAAAG-3 
R5  -GGGACACCGCTGATCGTTTATTTATAAATTTTTCTCCACTACTACTAAT-3 
Sequencing 5 -AATTTTAGAGTTTAAAGGGA-3 
Assay 5 -GYGGAGAYGGAGTATAATATTATAYGTATTATTAAYGTTAYGTAGTTTTT-3 
IL28RA XM 417841 F 5 -GGGACACCGCTGATCGTTTAAGGATGTGCGAGGTAGAATATTG-3 
R5  -CAAACCCTACAACAACCACATAAT-3 
Sequencing 5 -CCCTACAACAACCACATAA-3 
Assay 5 -TCRCTATATACTAACCRCCACRTTCCCAACAACRCACTAACRACTACAAC0A ATATTCTACCTCGCAC-3 
M0N2 NM 001199605 F 5 -TTATTGCGGTAGGGGTTAATATT-3 
R5  -GGGACACCGCTGATCGTTTA CAAACTAAACGCTATCCTAAACT-3 
Sequencing 5 -CGGTAGGGGTTAATATTTT-3 
Assay 5 -YGGGAGAYGTTAGYGGYGGGGATGGYGTTTTGTAGAGAGTAGTTTAGGATA-3 
THBS2 NM 001001755 F 5 -GGGACACCGCTGATCGTTTA GGGTGTATGTAGAAAAGGGAATGT-3 
R5  -TTCAACACGATACTATTCCTACCC-3 
Sequencing 5 -ACATAACTACATCTCCATAT-3 
Assay 5 -ACRTACRCTCCCACAATAAATAAAACAAACRACRACCRCTTAAACRTACAA ACATTCCCTTTTCTACATA
C-3 
CD44 NM_204860 F 5 -GTTTTTTTAAAATTTGTGTGGTTGT-3 
R5  -GGGACACCGCTGATCGTTTA AAACTCCATCAAAAATCACACC-3 
Sequencing 5 -GGTTGTTTAGTTAGAATTTA-3 
Assay 5 -YGGTTTTTYGYGGTTTTTTTTGTTTTGTTTCGTAAT-3 
IL12 NM_213588 F 5 -GTCGATGTCGTGTTTTGTTATGT-3 
R5  -GGGACACCGCTGATCGTTTA CCACGAAATTCCCAACTCTCA-3 
Sequencing 5 -TTTTGTTCGATGAAATTG-3 
Assay 5 -ATGYGGGATYGGTGGTTGTYGTAGGAGTTGYGTTGTTTTTATGTYGGTGG AGGAGTAGG AGTTTTTTTTT-3 
LATS2 XM417143 F 5 -GGGACACCGCTGATCGTTTATTTTGGTAGAAAGTTGGTGTGAAT-3 
R5  -CACCATATAACACTTCCCTACCTC-3 
Sequencing 5 -CCTACCTCACAAAAACC-3 
Assay 5 -TCRCCCRTCTTACAAACRATTCACCRTCTCRCCATCTTCTCCCCCRCTCCTTCAACTCRACRAATTCACA
CCAACTTTCTACCAAAA-3 
(Continued)
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TableA1 | Continued
Genes Accession No. Primers Sequence
GH NM_204359 F 5 -GGGACACCGCTGATCGTTTA GATTGGTGTGGAAAGGAGGAAGA-3 
R5  -CAAAAACAAATCGAACCCACAAC-3 
Sequencing 5 -CTCCTACAATTATCCATCC-3 
Assay 5 -CACRTTCTACCTCRTACRACTCAAAAATAAATATACTAAAACT-3 
IGF2 NM_001030342 F 5 -AAGTATAACGTGTGGTAGAAGAAGAGTT-3 
R5  -GGGACACCGCTGATCGTTTATCGCCCTAACTTCCTCAACTACT-3 
Sequencing 5 -CGTGTGGTAGAAGAAGAGT-3 
Assay 5 -TYGTAGYGGTTGTAGYGGGAGGTGTTAGGTATTTTGYGTGTTYGTYGGTATYGGTGGTAGGCGGAGGGG
TTGTAAGT-3 
TNFSF10 NM 204379 F 5 -GAGGGGAGGTTTAGGTTGGATATT-3 
R5  -GGGACACCGCTGATCGTTTA ACCGCCCACATCCCTCAATA-3 
Sequencing 5 -GGGGTGGAGTAGTGGTATA-3 
Assay 5 -GTYGTTYGGGGAGYGGTGGAGTTATYGTTTTTGGAAGTGTTTAGAGTYGTGGGGATGTGGTATTGAGGG
ATGT-3 
H2Ac NM_001079475 F 5 -AGTGGGGGACGTGCGAAATA-3 
R5  -GGGACACCGCTGATCGTTTA CCCCGCCCTTCCTCTTTTATAAC-3 
Sequencing 5 -TTATTGGGTAGATTTGGAT-3 
Assay 5 -TYGYGGYGTTATTGGTYGGAGYGAGTGAGAGAGTATATYGGTTAATYGGAAAGYGAGTYG
GGTYGTTGYGGGAGGTTATAAAAGAGGAAG GGCG-3 
CIITA NC 006101.2 F 5 -CGGGAATTTTTACGTTAGGTTTATAGTG-3 
R5  -GGGACACCGCTGATCGTTTAAACGCGAAACGAAAAAACTCCT-3 
Sequencing 5 -TTTTTACGTTAGGTTTATAG-3 
Assay 5 -TGTYGTYGYGGTATTTTAGTYGTTYGGTYGGGTTGYGGGGYGGTTTYGTTTTTTTTGGGGGYGGTTGTGGG
AGCGGAGGAGTTTTTT-3 
FABP3 NM 001030889 F 5 -AGAGGGGGAAATTGAGGTA-3 
R5  -GGGACACCGCTGATCGTTTA AACACACACACACGATCC-3 
Sequencing 5 -GGGGGAAATTGAGGTA-3 
Assay 5 -YGGGAGYGTTYGTGGGGATAYGYGGGATCGTGTGTGTGTGTTGGGGGT-3 
Y stands for C/T, and R stands for G/A. BoldY or R in the assay sequence is the CpG sites analyzed in each region.
TableA2 | Primers for quantitative real-time RT-PCR.
Genes Primers Sequence
ITGβ5 F5  -GTTTGGGGAGACCTGTGAGA-3 
R5  -TCATCCTTGCAGTGCTTTTG-3 
H2Ac F5  -CGGAAAGCAGGGCGGGAAG-3 
R5  -GTCAGGTACTCCAGCACGG-3 
DNMT1 F5  -CCACCAAAAGGAAATCAGAG-3 
R5  -TAATCCTCTTCTCATCTTGCT-3 
DNMT3a F5  -ATGAACGAGAAGGAAGACATC-3 
R5  -GCAAAGAGGTGGCGGATCAC-3 
DNMT3b F5  -CGTTACTTCTGGGGCAACCTC-3 
R5  -ATGACAGGGATGCTCCAGGAC-3 
GAPDH F5  -GAGGGTAGTGAAGGCTGCTG-3 
R5  -ACCAGGAAACAAGCTTGACG-3 
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TableA3 | Promoter Methylation levels of L63 and L72 not challenged with MDV.
Genes Lines CpG sites Note
1 2 3 4 5 6 7 8 Hypo.
LATS2 L63 0.73±0.91 0.12±0.41 3.60±2.33 0.56±0.84 1.19±1.31 0.71±1.30 1.13±2.49 0.32±0.64
L72 0.78±0.97 0.67±0.88 3.20±1.32 0.78±0.89 1.30±1.22 0.81±1.27 2.09±2.80 0.56±0.70
MON2 L63 1.04±1.37 1.50±1.48 1.59±1.80 0.99±1.80 0.57±1010 N/A/A N/A/A N/A/A
L72 1.94±1.11 1.34 ±1.50 2.47±3.25 1.53±2.09 1.01±1.30 N/A/A N/A/A N/A/A
IL28RA L63 4.77±1.14 7 .91±1.85 2.09±1.47 5.00±1.25 3.50±0.81 N/A/A N/A/A N/A/A
L72 3.90±1.08 7 .95±1.34 2.49±0.56 5.10±1.75 3.90±1.38 N/A/A N/A/A N/A/A
STAT1 L63 1.41±1.31 2.22±1.22 2.97±1.48 2.59±1.76 1.26 ±1.17 1.98 ±1.27 N/A/A N/A/A
L72 1.06±1.28 3.26±1.93 2.91±1.65 3.10±0.70 0.71±1.07 1.50±1.47 N/A/A N/A/A
CD44 L63 1.53±0.60 20.72±7 .08 0.58±0.16 15.10±3.39 N/A/A N/A/A N/A/A N/A/A
L72 1.94±1.02 6.73±1.43 3.04±0.91 6.76±0.93 N/A/A N/A/A N/A/A N/A/A
H2Ac L63 4.33±0.57 3.55±0.59 21.51±1.32 29.03±1.76 14.83±0.81 10.09±0.74 N/A/A N/A/A
L72 7 .81±0.91 6.16±1.02 31.18±1.75 38.50±1.25 20.48±0.87 16.50±0.87 N/A/A N/A/A
TNFSF10 L63 4.02±0.90 9.92±1.09 10.33±1.67 10.63±2.35 38.60±2.04 N/A/A N/A/A N/A/A
L72 5.48±1.58 8.93±3.23 13.15±2.42 9.91±3.54 25.07±3.75 N/A/A N/A/A N/A/A
IL12 L63 19.38±6.42 12.38±4.22 15.60±3.94 17 .02±4.29 7 .43±1.76 N/A/A N/A/A N/A/A
L72 24.25±4.29 14.57±3.30 18.30±2.01 21.22±4.25 8.78±2.16 N/A/A N/A/A N/A/A
FABP3 L63 35.99±7 .36 35.24±4.20 48.05±7 .12 32.69±4.39 4.16±1.81 20.43±8.12 N/A/A N/A/A
L72 28.22±6.60 30.27±8.05 39.98±12.15 28.38±7 .52 4.85±1.46 17 .03±5.14 N/A/A N/A/A
CIITA L63 25.57±4.55 29.20±6.72 4.26±3.64 3.22±2.96 N/A/A N/A/A N/A/A N/A/A
L72 19.76±7 .59 24.70±8.94 4.56±4.72 4.30±5.96 N/A/A N/A/A N/A/A N/A/A
ITGB5 L63 38.62±4.45 46.81±4.08 61.94±4.47 44.06±4.88 37 .74±1.32 39.63±1.57 N/A/A N/A/A Inter.
L72 52.04±4.62 61.32±4.76 71.83±3.54 56.37±4.09 40.05±1.86 41.53±5.97 N/A/A N/A/A
THBS2 L63 34.31±5.01 54.07±6.46 32.32±4.90 22.03±3.13 11.37±1.85 N/A/A N/A/A N/A/A
L72 49.45±5.16 70.68±5.04 41.68±4.63 30.91±3.82 14.08±1.45 N/A/A N/A/A N/A/A
HDAC9 L63 24.83±6.00 31.65±6.03 51.50±5.82 55.74±4.78 40.77±6.22 N/A/A N/A/A N/A/A
L72 36.80±5.36 45.83±4.20 64.86±6.47 68.25±3.94 54.15±3.48 N/A/A N/A/A N/A/A
IGF2 L63 89.69±4.08 89.25±2.35 88.05±3.85 77 .81±3.72 79.39±3.46 49.77±3.85 68.19±7 .40 88.95±1.92 Hyper.
L72 91.55±3.95 92.06±2.54 89.78±2.74 81.15±4.68 82.37±10.41 52.64±5.77 72.41±6.71 89.97±2.02
GH1 L63 63.12±2.75 48.64±2.51 80.64±2.54 N/A/A N/A/A N/A/A N/A/A N/A/A
L72 61.26±2.19 45.13±1.90 79.23±1.91 N/A/A N/A/A N/A/A N/A/A N/A/A
NK-lysin L63 89.47±2.33 42.98±5.29 82.46±2.20 78.32±1.72 62.63±2.16 N/A/A N/A/A N/A/A
L72 91.79±2.63 40.57±5.47 80.53±2.45 78.14±1.88 66.56±1.52 N/A/A N/A/A N/A/A
TGFB3 L63 88.04±1.60 90.98±2.19 90.39±2.28 80.86±1.60 68.43±2.13 74.39±3.46 N/A/A N/A/A
L72 89.88±2.59 92.91±2.58 93.51±2.66 82.90±2.09 72.94±3.09 77 .00±2.68 N/A/A N/A/A
CD82 L63 3.86±1.56 5.24±1.86 3.97±1.61 3.98±0.98 3.65±2.02 1.88±1.36 40.48±5.54 52.78±3.63 Hypo+
Inter. L72 3.16±0.99 4.41±1.31 3.59±1.12 4.41±1.40 2.69±1.23 1.85±1.27 41.22±5.29 51.61±2.67
Methylation level shown in each cell=mean±STD.
Hypo., hypomethylation; Hyper., hypermethylation; Inter., intermediate methylation.
N/A, data not available.
N=12 for each group.
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TableA4 | Promoter methylation level change at different CpG sites of genes after MDV challenge.
Gene name Time points (dpi) Lines % Methylation level change after MDV infection of different CpG sites
1 2 3 4 5 678
GH 5L 6 3 −5.09** −7 .44** −1.60
L72 3.29 1.50 4.07
10 L63 2.73* −1.00 0.95
L72 3.75* 1.04 −0.33
21 L63 0.50 2.08* −0.09
L72 6.87* 7 .10** 4.23**
CD44 5L 6 3 −0.23 0.71 −0.02 0.40
L72 0.40 −4.25 −1.26 0.36
10 L63 −0.56 2.39 −0.13 −1.63
L72 0.32 0.29 1.34 0.59
21 L63 0.03 −3.30 0.21 0.16
L72 −0.77 −3.17** −1.57 1.39
CIITA 5L 6 3 4.41 −3.23 1.50 5.11
L72 −11.86* −12.67 −2.78 −2.74
10 L63 −2.21 0.29 0.59 −1.60
L72 1.04 0.28 1.19 0.24
21 L63 −10.17** −6.12* 0.34 1.27
L72 −6.95** −5.83* 0.36 −1.18
NK-lysin 5L 6 3 4.24* 18.21** 6.25** 6.72** 1.20
L72 2.69 29.14** 4.23 4.82* −0.40
10 L63 1.61 8.62 1.63 3.46 1.28
L72 −1.03 7 .60 1.63 1.33 2.90
21 L63 −0.92* −3.59 −1.22 −1.55 −1.69**
L72 −1.69** −2.27 −2.06 −2.00* −1.99
THBS2 5L 6 3 8.06 7 .03 5.51 3.73 4.83
L72 −1.75 5.07 1.58 8.38 2.97
10 L63 5.74 6.32 0.61 2.03 0.05
L72 −1.25 1.46 0.33 −0.43 1.35
21 L63 −1.69 −1.38 2.49 1.50 2.07
L72 1.31 1.06 −0.20 −6.24 −0.06
M0N2 5L 6 3 0.63 −1.33 −2.87* −1.69 −0.10
L72 −1.43 2.22 0.35 −3.06 −0.09
10 L63 1.86 −0.62 0.59 0.75 0.41
L72 −1.17 −0.76 −5.96* 0.42 −0.52
21 L63 −0.33 0.43 0.56 0.29 −0.33
L72 0.94 −1.18 −0.63 0.64 −0.06
HDAC9 5L 6 3 5.28 8.65 6.56 6.04 7 .54
L72 3.37 11.67** −4.57 0.48 −3.20
10 L63 −4.07 1.41 3.86 −2.11 3.13
L72 −1.01 0.17 3.47 0.07 −1.60
21 L63 3.18 1.08 3.80 2.90 4.86
L72 12.56** 7 .00** 4.48 4.59 10.99**
FABP3 5L 6 3 7 .07 9.34* 15.81* 8.58* 3.22*
L72 7 .75 7 .22 10.96 8.09 0.13
10 L63 3.43 4.52 8.48 4.50 0.92
L72 −9.44* −11.67** −11.80** −10.82** −2.31**
21 L63 −8.35 −1.06 −2.23 0.03 2.81
L72 5.40 4.11 7 .09 4.15 2.74
(Continued)
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TableA4 | Continued
Gene name Time points (dpi) Lines % Methylation level change after MDV infection of different CpG sites
12345 6 7 8
IL28RA 5L 6 3 −1.87 −3.97* −0.54 −0.92 −0.46
L72 −2.75* −0.64 −1.12** −1.80 1.50
10 L63 −2.05** −0.60 −0.77 −0.65 0.02
L72 −1.67* −1.01 0.07 −1.15 0.70
21 L63 0.81 0.03 1.20 1.41 0.04
L72 0.11 0.65 −0.58 −0.12 0.21
IL12 5L 6 3 3.19* 4.27 −0.42 0.66 −1.46*
L72 −0.68 −0.68 0.13 −4.91 −1.43
10 L63 0.39 −0.88 0.60 −3.44 −0.28
L72 −1.07 −4.03 −1.05 −5.39 −1.00
21 L63 −2.02 −3.49 −3.58 0.12 −0.32
L72 3.06 1.85 −0.17 −3.05 1.08
TNFSF10 5L 6 3 0.23 −1.73* −1.70 −1.24 −1.11
L72 −0.25 −2.79* −3.72* −1.43 −2.24
10 L63 1.23 0.48 −0.19 0.81 −2.94
L72 −1.01 0.68 −1.19 0.06 1.80
21 L63 0.38 0.12 0.19 −1.29 −1.54
L72 −1.37 2.79 −2.24 2.07 3.67
ITGB5 5L 6 3 21.99** 24.91** 25.41** 21.58** 1.54* 0.38
L72 16.68** 20.25** 17 .04** 15.07** 1.73 −0.77
10 L63 3.73 −0.14 −3.03 −1.15 −0.24 −2.14
L72 −0.81 −2.01 −0.54 −1.81 −1.25 −2.76
21 L63 6.85 7 .81 5.15 6.66 2.51 1.05
L72 8.92 5.84 5.91 7 .19 2.30 1.75
STAT1 5L 6 3 −1.18 −1.20 −1.13 −1.69 −0.30 −0.19
L72 0.77 −1.10 0.23 −0.48 2.05* 1.07
10 L63 1.51* −0.35 −0.55 2.24** −0.62 0.64
L72 0.12 −0.86 0.01 1.39** −0.36 0.53
21 L63 0.95 −1.35 −1.98 −0.10 3.69* 1.46
L72 0.58 −3.86* −1.37 −1.86* 1.42 2.08*
TGFB3 5L 6 3 −0.44 4.22** 5.32 0.25** 6.90 5.63
L72 3.62 2.66 2.97* 2.38 2.15 −1.95
10 L63 1.34 0.84 −0.85** 3.36** 5.54 3.20
L72 −0.57 −2.24 −0.10 1.58 4.74 1.38
21 L63 2.38 3.58 3.92* −0.33 −1.25 −4.07
L72 −0.19 0.69 −0.34 −1.03 0.80 −0.13
H2AC 5L 6 3 0.63 0.65* 2.26 1.26 1.26 0.60
L72 2.79 1.25 4.58 3.69* 1.83 1.55
10 L63 1.14 1.13 4.78 4.98 2.27* 0.85**
L72 −0.15 0.14 −1.76** −1.40 0.12 −0.28
21 L63 0.60 0.25 0.95 1.61 0.22 1.04
L72 −1.47* 0.87 −3.09** −3.88** −0.72 0.13
CD82 5L 6 3 1.85 2.32 0.33 0.50 0.18 −0.47 −4.79 −2.36
L72 2.06 0.04 2.27 0.39 −0.57 −0.15 −5.52 −2.09
10 L63 −1.87* −2.07** −1.42 0.92 −2.17 3.88* 1.60 −0.24
L72 0.55 −0.80 −1.08 0.00 0.86 2.65 0.09 1.27
21 L63 0.21 0.88* −0.18 0.47 −0.50 0.44 −0.85 −1.30*
L72 2.01** 0.94* 1.19 3.10** 0.06 1.48 −1.77 −0.47
(Continued)
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TableA4 | Continued
Gene name Time points (dpi) Lines % Methylation level change after MDV infection of different CpG sites
1 2345 67 8
IGF2 5L 6 3 0.02* 2.83 0.16 3.50 −0.32 3.14 6.32* 2.45*
L72 2.19 1.47 0.82 3.70 −1.45 3.28 5.75 0.53
10 L63 −1.36 1.05 1.93 2.18 2.69 3.44 0.49 0.30
L72 −4.09 −1.95 −1.67 3.24 4.55* 3.60 −0.21 0.02
21 L63 0.34 0.64 −0.12 0.79 1.62 2.33 −3.51 0.22
L72 −1.23 0.10 −1.18 −1.32 4.91 5.46 2.08 −0.60
LATS2 5L 6 3 −0.21 1.04 −0.87 1.08 0.09 1.14 1.57 0.52
L72 0.32 0.25 −0.33 0.81 0.94 1.42 −1.65 0.48
10 L63 −0.02 0.27 −0.26 0.24 −0.87 −0.23 0.85 −0.03
L72 0.77 0.74 0.82 0.42 −0.27 0.55 0.41 0.38
21 L63 1.64* 0.67 0.80 0.62 0.69 0.48 1.31 0.60
L72 1.90* 0.74 −0.22 0.70 0.35 0.02 1.15 0.84
*P<0.05, **P<0.01.
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FIGUREA1 | Promoter methylation change during MDV life cycle in GH (A), HDAC9 (B), CIITA (C), STAT1 (D), H2Ac (E), LATS2 (F), and FABP3 (G).The
methylation change within lines was the methylation changed after MDV infection compared with the promoter methylation level before MDV infection. N=4
for each group.
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